A2AJX4 · MALR1_MOUSE
- ProteinMAM and LDL-receptor class A domain-containing protein 1
- GeneMalrd1
- StatusUniProtKB reviewed (Swiss-Prot)
- Organism
- Amino acids2123 (go to sequence)
- Protein existenceEvidence at protein level
- Annotation score5/5
Function
function
Enhances production and/or transport of FGF15 and thus has a role in regulation of bile acid synthesis.
GO annotations
all annotations | all molecular function | virus receptor activity | dna binding | rna binding | cytoskeletal motor activity | catalytic activity | gtpase activity | structural molecule activity | transporter activity | cytoskeletal protein binding | lipid binding | cyclase activity | antioxidant activity | oxidoreductase activity | transferase activity | hydrolase activity | lyase activity | isomerase activity | ligase activity | protein tag activity | cargo receptor activity | histone binding | protein folding chaperone | translation regulator activity | nutrient reservoir activity | receptor ligand activity | molecular transducer activity | molecular adaptor activity | toxin activity | cell adhesion mediator activity | molecular function regulator activity | virus coreceptor activity | catalytic activity, acting on a protein | catalytic activity, acting on dna | catalytic activity, acting on rna | molecular carrier activity | transcription regulator activity | general transcription initiation factor activity | molecular sensor activity | molecular sequestering activity | atp-dependent activity | other molecular function | all biological process | mitotic cell cycle | cytokinesis | cytoplasmic translation | immune system process | muscle system process | circulatory system process | renal system process | respiratory system process | carbohydrate metabolic process | generation of precursor metabolites and energy | dna replication | dna repair | dna recombination | chromatin organization | dna-templated transcription | regulation of dna-templated transcription | trna metabolic process | protein folding | protein glycosylation | amino acid metabolic process | modified amino acid metabolic process | lipid metabolic process | vitamin metabolic process | sulfur compound metabolic process | intracellular protein transport | nucleocytoplasmic transport | autophagy | inflammatory response | mitochondrion organization | cytoskeleton organization | microtubule-based movement | peroxisome organization | lysosome organization | chromosome segregation | cell adhesion | establishment or maintenance of cell polarity | programmed cell death | photosynthesis | mrna metabolic process | snrna metabolic process | vesicle-mediated transport | reproductive process | digestive system process | signaling | cell differentiation | protein catabolic process | extracellular matrix organization | regulatory ncrna-mediated gene silencing | telomere organization | cell junction organization | wound healing | ribosome biogenesis | cilium organization | anatomical structure development | cell motility | nervous system process | endocrine process | protein maturation | transmembrane transport | nucleobase-containing small molecule metabolic process | hepaticobiliary system process | membrane organization | protein-containing complex assembly | cell wall organization or biogenesis | nitrogen cycle metabolic process | protein localization to plasma membrane | defense response to other organism | detoxification | meiotic nuclear division | mitotic nuclear division | mitochondrial gene expression | carbohydrate derivative metabolic process | other biological process | all cellular component | nuclear chromosome | extracellular region | extracellular space | cell wall | nucleus | nuclear envelope | nucleoplasm | chromosome | nucleolus | mitochondrion | lysosome | endosome | vacuole | peroxisome | endoplasmic reticulum | golgi apparatus | lipid droplet | microtubule organizing center | cytosol | ribosome | cytoskeleton | plasma membrane | cilium | plastid | thylakoid | external encapsulating structure | extracellular matrix | cytoplasmic vesicle | organelle | other cellular component | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aspect | Term | |
---|---|---|
Cellular Component | cytoplasm | |
Cellular Component | cytoplasmic vesicle membrane | |
Cellular Component | Golgi apparatus | |
Biological Process | cholesterol homeostasis | |
Biological Process | negative regulation of bile acid biosynthetic process |
Names & Taxonomy
Protein names
- Recommended nameMAM and LDL-receptor class A domain-containing protein 1
Gene names
Organism names
- Organism
- Strain
- Taxonomic lineageEukaryota > Metazoa > Chordata > Craniata > Vertebrata > Euteleostomi > Mammalia > Eutheria > Euarchontoglires > Glires > Rodentia > Myomorpha > Muroidea > Muridae > Murinae > Mus > Mus
Accessions
- Primary accessionA2AJX4
- Secondary accessions
Proteomes
Organism-specific databases
Subcellular Location
UniProt Annotation
GO Annotation
Cytoplasmic vesicle membrane ; Single-pass type I membrane protein
Features
Showing features for topological domain, transmembrane.
Type | ID | Position(s) | Description | |||
---|---|---|---|---|---|---|
Topological domain | 27-2039 | Vesicular | ||||
Sequence: ISPLSQQGVQAFQCSNGVSLPSDYVCDFTDHCGDNSEEQQCWSYGRCNFEDRLCSMTEDQTLQPGWTRRSGIISNSPPFWDHNGNISAHFLALVSRVDSISSNLRSRIFLPTNDQQVCQITFYNFSSNQNGKLIAGLQTLCGDPIEHLWQKTEILQSRWERNVITVQSSQQFQVIFQAQMLATHGQEEVIAIDDISFSSGCLPADVCQTCGFDLDTCGLATEASAGRTSWMCTKVREIPSLDSVPWQDQRGHDEGSFVWMRAGHASVSRLVESSAYLNSSVCHCMDGNCRLQFNYTMENSILRVRLYNDKEEKKTWTFNTSTYSTWMKADVLIPEDLKAFKVVLEGTVLSQKSFIGIDQLLVYNFGQTHSQKLCSVNEYTPASRQCLTHSSVCDSGMDHSNGIDEDSEACASLLTWDFESGFCGWEPFPTEDSHWEVVRGLSNGEHLFLEAGHTVSRNQGSFIYFGPQKSTAVARLGSPILTKSLTTFTPCQVRFWYHLSEHSSLSVFTRTSVDGSLLKQSEVTQFSDSQWSQAKVDLHAKAEESTLPFQLVLEATILSSNATVAVDDISISHECEISYKSLRSTSIQNKVADCDFEANSCGWFEASGGDHFDWVWSSQSNLSADLEQQAPPRDHTHGTAQGHFMFILKTSNSLFQTAKLQSPTFSQTGPGCTMSFWFYNYGLSVGAAELQLHLENSRDTTALWRVLYNQGNQWSEATVQLGRLTQPFYLSLEKVSLAVYSGVSAVDDIHFENCALPPPVESCDEPDHFWCRQTKACIGRHQLCDLVDDCGDYTDETGCAPGLQCNFENGICNWEQSTKDDFNWTRYQGPTSTMNTGPMKDHTLGTAKGHYLYIETSGPQGFQDKAVLLSPILNATEAKVCTFRLYYHMFGKHIYRLAIYQRIWSNTKGQLLWQIFGDQGNRWIRKDLSITSRKPFQILIMASVGDGFTGDIAIDDLSFMDCTLYPDNLPMDIPSPPETSVPVTLPPNNCTDDQFVCRSNGHCVGNIQKCDFRYDCIDKSDESSCVLEVCTFEERKLCKWYQPIPANSLHDSNTFRWGLGNGISIHHGEENHRPSVDHTKNTTDGWYLYADSSNGKFGDLADIVTPVISLMGPRCTLVFWTYMNGATVGSLQVLIKMGNTISKVWAQSGQQGPQWKKAEVFLGIHSHVEIVFRAKRGVSYIGDVAVDDVSFQNCSPLLSTNRKCTTDEFMCANKHCIEKDKLCDFVNDCADNSDETTFICGTSSGRCDFEFDLCTWEQDQDEDIDWNLKASNIPATSTEPAVDHTLGNSSGHYIILKSFFPQQPVKTGRISSPVISKRSKDCKIIFNYHMYGSGIAALLLLQVTVTNHTRVLLNLTKEQGNFWQRKELSLSSDEDFRVKFEGRVGEGIRGNIALDDIVLTKSCLPSHHSTREEPAFPLPTGFCPRGYEECQNGRCYSPEQRCNFVDDCGDNSDENECGGSCTFEKGWCGWKNSLAENSDWVLGIGSYKSQRPPKDHTLGNEHGHFMYLEATPVGLHGDKAHFKSATWQESSAACTMSFWYFISAKATGSIQILIKTDKGLWEVWQQSKPDPGNHWRRATILLGKLRNFEVIFQGIRTRDLGGGAAIDDIEFNNCTTVGETTDICSEETDFLCQDKKCIASHLVCDYKPDCSDTSDEAHCGYYTSTAGSCNFETTSGDWTVECGLTQDPEDDLDWSIGSIIPTEGLSRDSDHTPGSGRHFLYVNTSLAEEGSTARIITSHFFPASLGICTVRFWFYMVDPHIVGILKVYLIEKSGLNILMWSMMRNKNTGWTYAHVPLSSNSPFKVAFEADLGGKEDIFIALDDITFTPTCASGGPALPQPPLCEEGQFACIYALQCVSASEKCDGQEDCIDGSDEMNCSLGPSPQPCSDTEFQCFESQCIPSLLLCDGVADCQFNEDESSCVNQSCPSGALACNSSGLCIPAHQRCDGTAHCKDIQVDESSCSECPIHYCRNGGTCVIENIGPTCRCVQGWTGNRCHIRSNLSTEGSVHTQNY | ||||||
Transmembrane | 2040-2060 | Helical | ||||
Sequence: IWTLLGIGLGFLLTHIAVAIL | ||||||
Topological domain | 2061-2123 | Cytoplasmic | ||||
Sequence: CSLGIRRRPMRKSEGVGNHSFINPVYRNCINQEKTQSSIYSFPNPFYGAASGSLETVSHHLKS |
Keywords
- Cellular component
Phenotypes & Variants
Disruption phenotype
Viable, with enhanced resistance to diet-induced hypercholesterolemia and atherosclerosis (PubMed:10744778).
Increased bile acid levels in blood, liver and gastrointestinal tract, associated with significantly reduced levels of FGF15 in the ileum (PubMed:23747249).
Increased bile acid levels in blood, liver and gastrointestinal tract, associated with significantly reduced levels of FGF15 in the ileum (PubMed:23747249).
Variants
We now provide the "Disease & Variants" viewer in its own tab.
The viewer provides 97 variants from UniProt as well as other sources including ClinVar and dbSNP.
PTM/Processing
Features
Showing features for signal, chain, disulfide bond, glycosylation.
Type | ID | Position(s) | Description | |||
---|---|---|---|---|---|---|
Signal | 1-26 | |||||
Sequence: MFLPKAAVSAFSMHGSLCFLWTVCLS | ||||||
Chain | PRO_5007184230 | 27-2123 | MAM and LDL-receptor class A domain-containing protein 1 | |||
Sequence: ISPLSQQGVQAFQCSNGVSLPSDYVCDFTDHCGDNSEEQQCWSYGRCNFEDRLCSMTEDQTLQPGWTRRSGIISNSPPFWDHNGNISAHFLALVSRVDSISSNLRSRIFLPTNDQQVCQITFYNFSSNQNGKLIAGLQTLCGDPIEHLWQKTEILQSRWERNVITVQSSQQFQVIFQAQMLATHGQEEVIAIDDISFSSGCLPADVCQTCGFDLDTCGLATEASAGRTSWMCTKVREIPSLDSVPWQDQRGHDEGSFVWMRAGHASVSRLVESSAYLNSSVCHCMDGNCRLQFNYTMENSILRVRLYNDKEEKKTWTFNTSTYSTWMKADVLIPEDLKAFKVVLEGTVLSQKSFIGIDQLLVYNFGQTHSQKLCSVNEYTPASRQCLTHSSVCDSGMDHSNGIDEDSEACASLLTWDFESGFCGWEPFPTEDSHWEVVRGLSNGEHLFLEAGHTVSRNQGSFIYFGPQKSTAVARLGSPILTKSLTTFTPCQVRFWYHLSEHSSLSVFTRTSVDGSLLKQSEVTQFSDSQWSQAKVDLHAKAEESTLPFQLVLEATILSSNATVAVDDISISHECEISYKSLRSTSIQNKVADCDFEANSCGWFEASGGDHFDWVWSSQSNLSADLEQQAPPRDHTHGTAQGHFMFILKTSNSLFQTAKLQSPTFSQTGPGCTMSFWFYNYGLSVGAAELQLHLENSRDTTALWRVLYNQGNQWSEATVQLGRLTQPFYLSLEKVSLAVYSGVSAVDDIHFENCALPPPVESCDEPDHFWCRQTKACIGRHQLCDLVDDCGDYTDETGCAPGLQCNFENGICNWEQSTKDDFNWTRYQGPTSTMNTGPMKDHTLGTAKGHYLYIETSGPQGFQDKAVLLSPILNATEAKVCTFRLYYHMFGKHIYRLAIYQRIWSNTKGQLLWQIFGDQGNRWIRKDLSITSRKPFQILIMASVGDGFTGDIAIDDLSFMDCTLYPDNLPMDIPSPPETSVPVTLPPNNCTDDQFVCRSNGHCVGNIQKCDFRYDCIDKSDESSCVLEVCTFEERKLCKWYQPIPANSLHDSNTFRWGLGNGISIHHGEENHRPSVDHTKNTTDGWYLYADSSNGKFGDLADIVTPVISLMGPRCTLVFWTYMNGATVGSLQVLIKMGNTISKVWAQSGQQGPQWKKAEVFLGIHSHVEIVFRAKRGVSYIGDVAVDDVSFQNCSPLLSTNRKCTTDEFMCANKHCIEKDKLCDFVNDCADNSDETTFICGTSSGRCDFEFDLCTWEQDQDEDIDWNLKASNIPATSTEPAVDHTLGNSSGHYIILKSFFPQQPVKTGRISSPVISKRSKDCKIIFNYHMYGSGIAALLLLQVTVTNHTRVLLNLTKEQGNFWQRKELSLSSDEDFRVKFEGRVGEGIRGNIALDDIVLTKSCLPSHHSTREEPAFPLPTGFCPRGYEECQNGRCYSPEQRCNFVDDCGDNSDENECGGSCTFEKGWCGWKNSLAENSDWVLGIGSYKSQRPPKDHTLGNEHGHFMYLEATPVGLHGDKAHFKSATWQESSAACTMSFWYFISAKATGSIQILIKTDKGLWEVWQQSKPDPGNHWRRATILLGKLRNFEVIFQGIRTRDLGGGAAIDDIEFNNCTTVGETTDICSEETDFLCQDKKCIASHLVCDYKPDCSDTSDEAHCGYYTSTAGSCNFETTSGDWTVECGLTQDPEDDLDWSIGSIIPTEGLSRDSDHTPGSGRHFLYVNTSLAEEGSTARIITSHFFPASLGICTVRFWFYMVDPHIVGILKVYLIEKSGLNILMWSMMRNKNTGWTYAHVPLSSNSPFKVAFEADLGGKEDIFIALDDITFTPTCASGGPALPQPPLCEEGQFACIYALQCVSASEKCDGQEDCIDGSDEMNCSLGPSPQPCSDTEFQCFESQCIPSLLLCDGVADCQFNEDESSCVNQSCPSGALACNSSGLCIPAHQRCDGTAHCKDIQVDESSCSECPIHYCRNGGTCVIENIGPTCRCVQGWTGNRCHIRSNLSTEGSVHTQNYIWTLLGIGLGFLLTHIAVAILCSLGIRRRPMRKSEGVGNHSFINPVYRNCINQEKTQSSIYSFPNPFYGAASGSLETVSHHLKS | ||||||
Disulfide bond | 40↔58 | |||||
Sequence: CSNGVSLPSDYVCDFTDHC | ||||||
Disulfide bond | 52↔67 | |||||
Sequence: CDFTDHCGDNSEEQQC | ||||||
Glycosylation | 111 | N-linked (GlcNAc...) asparagine | ||||
Sequence: N | ||||||
Disulfide bond | 400↔412 | |||||
Sequence: CSVNEYTPASRQC | ||||||
Disulfide bond | 419↔436 | |||||
Sequence: CDSGMDHSNGIDEDSEAC | ||||||
Disulfide bond | 789↔803 | |||||
Sequence: CDEPDHFWCRQTKAC | ||||||
Disulfide bond | 797↔816 | |||||
Sequence: CRQTKACIGRHQLCDLVDDC | ||||||
Disulfide bond | 810↔825 | |||||
Sequence: CDLVDDCGDYTDETGC | ||||||
Glycosylation | 1015 | N-linked (GlcNAc...) asparagine | ||||
Sequence: N | ||||||
Disulfide bond | 1016↔1029 | |||||
Sequence: CTDDQFVCRSNGHC | ||||||
Disulfide bond | 1023↔1042 | |||||
Sequence: CRSNGHCVGNIQKCDFRYDC | ||||||
Disulfide bond | 1036↔1051 | |||||
Sequence: CDFRYDCIDKSDESSC | ||||||
Disulfide bond | 1230↔1242 | |||||
Sequence: CTTDEFMCANKHC | ||||||
Disulfide bond | 1237↔1255 | |||||
Sequence: CANKHCIEKDKLCDFVNDC | ||||||
Disulfide bond | 1249↔1266 | |||||
Sequence: CDFVNDCADNSDETTFIC | ||||||
Glycosylation | 1380 | N-linked (GlcNAc...) asparagine | ||||
Sequence: N | ||||||
Disulfide bond | 1449↔1461 | |||||
Sequence: CPRGYEECQNGRC | ||||||
Disulfide bond | 1456↔1474 | |||||
Sequence: CQNGRCYSPEQRCNFVDDC | ||||||
Disulfide bond | 1468↔1483 | |||||
Sequence: CNFVDDCGDNSDENEC | ||||||
Disulfide bond | 1650↔1663 | |||||
Sequence: CSEETDFLCQDKKC | ||||||
Disulfide bond | 1658↔1676 | |||||
Sequence: CQDKKCIASHLVCDYKPDC | ||||||
Disulfide bond | 1670↔1685 | |||||
Sequence: CDYKPDCSDTSDEAHC | ||||||
Glycosylation | 1749 | N-linked (GlcNAc...) asparagine | ||||
Sequence: N | ||||||
Disulfide bond | 1869↔1882 | |||||
Sequence: CEEGQFACIYALQC | ||||||
Disulfide bond | 1876↔1895 | |||||
Sequence: CIYALQCVSASEKCDGQEDC | ||||||
Disulfide bond | 1889↔1904 | |||||
Sequence: CDGQEDCIDGSDEMNC | ||||||
Disulfide bond | 1913↔1925 | |||||
Sequence: CSDTEFQCFESQC | ||||||
Disulfide bond | 1920↔1938 | |||||
Sequence: CFESQCIPSLLLCDGVADC | ||||||
Disulfide bond | 1932↔1947 | |||||
Sequence: CDGVADCQFNEDESSC | ||||||
Disulfide bond | 1952↔1965 | |||||
Sequence: CPSGALACNSSGLC | ||||||
Disulfide bond | 1959↔1978 | |||||
Sequence: CNSSGLCIPAHQRCDGTAHC | ||||||
Disulfide bond | 1972↔1988 | |||||
Sequence: CDGTAHCKDIQVDESSC | ||||||
Disulfide bond | 1991↔2002 | |||||
Sequence: CPIHYCRNGGTC | ||||||
Disulfide bond | 1996↔2011 | |||||
Sequence: CRNGGTCVIENIGPTC | ||||||
Disulfide bond | 2013↔2022 | |||||
Sequence: CVQGWTGNRC |
Keywords
- PTM
Proteomic databases
PTM databases
Expression
Tissue specificity
Strongly expressed in epithelial cells of the small intestine. Also detected in kidney cortex, and testis.
Gene expression databases
Structure
Family & Domains
Features
Showing features for domain.
Type | ID | Position(s) | Description | |||
---|---|---|---|---|---|---|
Domain | 27-68 | LDL-receptor class A 1 | ||||
Sequence: ISPLSQQGVQAFQCSNGVSLPSDYVCDFTDHCGDNSEEQQCW | ||||||
Domain | 71-235 | MAM 1 | ||||
Sequence: GRCNFEDRLCSMTEDQTLQPGWTRRSGIISNSPPFWDHNGNISAHFLALVSRVDSISSNLRSRIFLPTNDQQVCQITFYNFSSNQNGKLIAGLQTLCGDPIEHLWQKTEILQSRWERNVITVQSSQQFQVIFQAQMLATHGQEEVIAIDDISFSSGCLPADVCQT | ||||||
Domain | 234-402 | MAM 2 | ||||
Sequence: QTCGFDLDTCGLATEASAGRTSWMCTKVREIPSLDSVPWQDQRGHDEGSFVWMRAGHASVSRLVESSAYLNSSVCHCMDGNCRLQFNYTMENSILRVRLYNDKEEKKTWTFNTSTYSTWMKADVLIPEDLKAFKVVLEGTVLSQKSFIGIDQLLVYNFGQTHSQKLCSV | ||||||
Domain | 399-437 | LDL-receptor class A 2 | ||||
Sequence: LCSVNEYTPASRQCLTHSSVCDSGMDHSNGIDEDSEACA | ||||||
Domain | 443-603 | MAM 3 | ||||
Sequence: DFESGFCGWEPFPTEDSHWEVVRGLSNGEHLFLEAGHTVSRNQGSFIYFGPQKSTAVARLGSPILTKSLTTFTPCQVRFWYHLSEHSSLSVFTRTSVDGSLLKQSEVTQFSDSQWSQAKVDLHAKAEESTLPFQLVLEATILSSNATVAVDDISISHECEI | ||||||
Domain | 618-782 | MAM 4 | ||||
Sequence: ADCDFEANSCGWFEASGGDHFDWVWSSQSNLSADLEQQAPPRDHTHGTAQGHFMFILKTSNSLFQTAKLQSPTFSQTGPGCTMSFWFYNYGLSVGAAELQLHLENSRDTTALWRVLYNQGNQWSEATVQLGRLTQPFYLSLEKVSLAVYSGVSAVDDIHFENCAL | ||||||
Domain | 788-826 | LDL-receptor class A 3 | ||||
Sequence: SCDEPDHFWCRQTKACIGRHQLCDLVDDCGDYTDETGCA | ||||||
Domain | 829-990 | MAM 5 | ||||
Sequence: LQCNFENGICNWEQSTKDDFNWTRYQGPTSTMNTGPMKDHTLGTAKGHYLYIETSGPQGFQDKAVLLSPILNATEAKVCTFRLYYHMFGKHIYRLAIYQRIWSNTKGQLLWQIFGDQGNRWIRKDLSITSRKPFQILIMASVGDGFTGDIAIDDLSFMDCTL | ||||||
Domain | 1015-1052 | LDL-receptor class A 4 | ||||
Sequence: NCTDDQFVCRSNGHCVGNIQKCDFRYDCIDKSDESSCV | ||||||
Domain | 1054-1222 | MAM 6 | ||||
Sequence: EVCTFEERKLCKWYQPIPANSLHDSNTFRWGLGNGISIHHGEENHRPSVDHTKNTTDGWYLYADSSNGKFGDLADIVTPVISLMGPRCTLVFWTYMNGATVGSLQVLIKMGNTISKVWAQSGQQGPQWKKAEVFLGIHSHVEIVFRAKRGVSYIGDVAVDDVSFQNCSP | ||||||
Domain | 1229-1267 | LDL-receptor class A 5 | ||||
Sequence: KCTTDEFMCANKHCIEKDKLCDFVNDCADNSDETTFICG | ||||||
Domain | 1271-1431 | MAM 7 | ||||
Sequence: GRCDFEFDLCTWEQDQDEDIDWNLKASNIPATSTEPAVDHTLGNSSGHYIILKSFFPQQPVKTGRISSPVISKRSKDCKIIFNYHMYGSGIAALLLLQVTVTNHTRVLLNLTKEQGNFWQRKELSLSSDEDFRVKFEGRVGEGIRGNIALDDIVLTKSCLP | ||||||
Domain | 1448-1484 | LDL-receptor class A 6 | ||||
Sequence: FCPRGYEECQNGRCYSPEQRCNFVDDCGDNSDENECG | ||||||
Domain | 1485-1642 | MAM 8 | ||||
Sequence: GSCTFEKGWCGWKNSLAENSDWVLGIGSYKSQRPPKDHTLGNEHGHFMYLEATPVGLHGDKAHFKSATWQESSAACTMSFWYFISAKATGSIQILIKTDKGLWEVWQQSKPDPGNHWRRATILLGKLRNFEVIFQGIRTRDLGGGAAIDDIEFNNCTT | ||||||
Domain | 1649-1686 | LDL-receptor class A 7 | ||||
Sequence: ICSEETDFLCQDKKCIASHLVCDYKPDCSDTSDEAHCG | ||||||
Domain | 1693-1858 | MAM 9 | ||||
Sequence: GSCNFETTSGDWTVECGLTQDPEDDLDWSIGSIIPTEGLSRDSDHTPGSGRHFLYVNTSLAEEGSTARIITSHFFPASLGICTVRFWFYMVDPHIVGILKVYLIEKSGLNILMWSMMRNKNTGWTYAHVPLSSNSPFKVAFEADLGGKEDIFIALDDITFTPTCAS | ||||||
Domain | 1868-1905 | LDL-receptor class A 8 | ||||
Sequence: LCEEGQFACIYALQCVSASEKCDGQEDCIDGSDEMNCS | ||||||
Domain | 1912-1948 | LDL-receptor class A 9 | ||||
Sequence: PCSDTEFQCFESQCIPSLLLCDGVADCQFNEDESSCV | ||||||
Domain | 1951-1989 | LDL-receptor class A 10 | ||||
Sequence: SCPSGALACNSSGLCIPAHQRCDGTAHCKDIQVDESSCS | ||||||
Domain | 1990-2023 | EGF-like | ||||
Sequence: ECPIHYCRNGGTCVIENIGPTCRCVQGWTGNRCH |
Keywords
- Domain
Phylogenomic databases
Family and domain databases
Sequence
- Sequence statusComplete
- Sequence processingThe displayed sequence is further processed into a mature form.
- Length2,123
- Mass (Da)236,194
- Last updated2015-02-04 v2
- ChecksumBD6937E5F0C08F21
Keywords
- Technical term
Sequence databases
Nucleotide Sequence | Protein Sequence | Molecule Type | Status | |
---|---|---|---|---|
KC836882 EMBL· GenBank· DDBJ | AGN95783.1 EMBL· GenBank· DDBJ | mRNA | ||
AL772224 EMBL· GenBank· DDBJ | - | Genomic DNA | No translation available. | |
AL844839 EMBL· GenBank· DDBJ | - | Genomic DNA | No translation available. | |
AL845271 EMBL· GenBank· DDBJ | - | Genomic DNA | No translation available. | |
AL845417 EMBL· GenBank· DDBJ | - | Genomic DNA | No translation available. | |
AL845543 EMBL· GenBank· DDBJ | - | Genomic DNA | No translation available. | |
AL928841 EMBL· GenBank· DDBJ | - | Genomic DNA | No translation available. | |
AL935116 EMBL· GenBank· DDBJ | - | Genomic DNA | No translation available. |